Natpar(a): A Case in Point for Rare Disease Drugs? Natpar(a): A Case in Point for Rare Disease Drugs?
The US recall of recombinant parathyroid hormone Natpara has shone a light on reimbursement issues in the UK and other EU countries, where it ' s known as Natpar; patients are frustrated.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news